A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.
NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, and led by Professor Paolo A. Ascierto of the Istituto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback